Package 72888-229-67

Brand: topiramate

Generic: topiramate
NDC Package

Package Facts

Identity

Package NDC 72888-229-67
Digits Only 7288822967
Product NDC 72888-229
Product ID 72888-229_382d2706-227f-1962-e063-6394a90a147b
Description

240 CAPSULE in 1 BOTTLE (72888-229-67)

Marketing

Marketing Status
Marketed Since 2025-05-27
Brand topiramate
Generic topiramate
Sample Package No

Linked Drug Pages (1)

Topiramate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "382d2706-227f-1962-e063-6394a90a147b", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0372888228051", "0372888230672", "0372888228679", "0372888229126", "0372888229676", "0372888230054", "0372888228129", "0372888228303", "0372888229607", "0372888230122", "0372888228600", "0372888229058", "0372888230603", "0372888230306"], "unii": ["0H73WJJ391"], "rxcui": ["205315", "205316", "252413"], "spl_set_id": ["48169bbc-4fb2-4bc4-9bdd-de71bf7722df"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Advagen Pharma Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 CAPSULE in 1 BOTTLE (72888-229-05)", "package_ndc": "72888-229-05", "marketing_start_date": "20250527"}, {"sample": false, "description": "120 CAPSULE in 1 BOTTLE (72888-229-12)", "package_ndc": "72888-229-12", "marketing_start_date": "20250527"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (72888-229-30)", "package_ndc": "72888-229-30", "marketing_start_date": "20250527"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (72888-229-60)", "package_ndc": "72888-229-60", "marketing_start_date": "20250527"}, {"sample": false, "description": "240 CAPSULE in 1 BOTTLE (72888-229-67)", "package_ndc": "72888-229-67", "marketing_start_date": "20250527"}], "brand_name": "Topiramate", "product_id": "72888-229_382d2706-227f-1962-e063-6394a90a147b", "dosage_form": "CAPSULE", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "72888-229", "generic_name": "Topiramate", "labeler_name": "Advagen Pharma Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "25 mg/1"}], "application_number": "ANDA216683", "marketing_category": "ANDA", "marketing_start_date": "20250527", "listing_expiration_date": "20261231"}